Project measures / variables set:   Rusyn2   DCV_cysteine_tce

ID, description, units MPD:36185   DCV_cysteine_tce   DCV cysteine (serum DCVC x 10-3)   [nmol/mL]  
trichloroethylene study
Measures • time after treatment: 2h    • 8h    • 24h
Data set, strains Rusyn2   inbred   16 strains     sex: m     age: 7wks
Procedure drug and metabolite quantification
Comparisontimecourse but different cohorts
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

Rusyn2 - DCV cysteine (serum DCVC x 10-3)





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
time 2 4.3018 2.1509 77.2886 < 0.0001
strain 1 4.7243 4.7243 169.7581 < 0.0001
time:strain 2 4.184 2.092 75.171 < 0.0001
Residuals 9 0.2505 0.0278

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested
SexAge
Rusyn2 36185 drug and metabolite quantification trichloroethylene DCV cysteine (serum DCVC x 10-3)   [nmol/mL]   2h after treatment  DCV_cysteine2_tce inbred 15 m 7wks
Rusyn2 36186 drug and metabolite quantification trichloroethylene DCV cysteine (serum DCVC x 10-3)   [nmol/mL]   8h after treatment  DCV_cysteine8_tce inbred 13 m 7wks
Rusyn2 36187 drug and metabolite quantification trichloroethylene DCV cysteine (serum DCVC x 10-3)   [nmol/mL]   24h after treatment  DCV_cysteine24_tce inbred 7 m 7wks